These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7574683)
1. Interactions of gelatinases with soluble and immobilized fetuin and asialofetuin. Ochieng J; Warfield P; Green B Arch Biochem Biophys; 1995 Sep; 322(1):250-5. PubMed ID: 7574683 [TBL] [Abstract][Full Text] [Related]
2. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line. Wu AJ; Lafrenie RM; Park C; Apinhasmit W; Chen ZJ; Birkedal-Hansen H; Yamada KM; Stetler-Stevenson WG; Baum BJ J Cell Physiol; 1997 May; 171(2):117-24. PubMed ID: 9130458 [TBL] [Abstract][Full Text] [Related]
3. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346 [TBL] [Abstract][Full Text] [Related]
4. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Fridman R; Toth M; Peña D; Mobashery S Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967 [TBL] [Abstract][Full Text] [Related]
5. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498 [TBL] [Abstract][Full Text] [Related]
6. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444 [TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
8. Interaction of matrix metalloproteinases-2 and -9 with pregnancy zone protein and alpha2-macroglobulin. Arbeláez LF; Bergmann U; Tuuttila A; Shanbhag VP; Stigbrand T Arch Biochem Biophys; 1997 Nov; 347(1):62-8. PubMed ID: 9344465 [TBL] [Abstract][Full Text] [Related]
9. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888 [TBL] [Abstract][Full Text] [Related]
10. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659 [TBL] [Abstract][Full Text] [Related]
12. Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A. Miyamori H; Takino T; Seiki M; Sato H Biochem Biophys Res Commun; 2000 Jan; 267(3):796-800. PubMed ID: 10673371 [TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. Xie B; Dong Z; Fidler IJ J Immunol; 1994 Apr; 152(7):3637-44. PubMed ID: 8144939 [TBL] [Abstract][Full Text] [Related]
14. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides. Xia T; Akers K; Eisen AZ; Seltzer JL Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. Zervos EE; Shafii AE; Rosemurgy AS J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060 [TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Kherif S; Lafuma C; Dehaupas M; Lachkar S; Fournier JG; Verdière-Sahuqué M; Fardeau M; Alameddine HS Dev Biol; 1999 Jan; 205(1):158-70. PubMed ID: 9882504 [TBL] [Abstract][Full Text] [Related]
19. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. Mäkelä M; Salo T; Uitto VJ; Larjava H J Dent Res; 1994 Aug; 73(8):1397-406. PubMed ID: 8083435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]